Karl Anker Jørgensen received his PhD from Aarhus Univer- sity in 1984. He was a post- doc with Professor Roald Hoffmann, Cornell University, during 1985. In 1985 Karl Anker Jørgensen became an assistant Professor at Aarhus University and became Profes- sor at the same place in 1992. His research interest is the development, understanding and application of asymmetric catalysis.
Eiichi Nakamura received his PhD from Tokyo Institute of Technology, and did his postdoc- toral work at Columbia University. He returned to his alma mater as Assistant Professor (1980- 1984), promoted to Full Professor (1993), and moved to the present position at the University of Tokyo in 1995. He has served as Senior Program Officer in Chemistry, JSPS (2003-2007) and ERATO program research director, JST (2004-2010).
Awards and Honors: Young Chemists Award (Chemical Society of Japan, 1984); The Japan IBM Science Prize (1993); Elected Fellow of the American Association for the Advancement of Science (1998); The Chemical Society of Japan Award (2003); Elected Foreign Fellow of the Royal Society of Chemistry (U.K., 2005); Humboldt Research Award (2006); Honorary Foreign Member of the American Academy of Arts and Sciences (2008), The Medal with Purple Ribbon, The Japanese Government (2009), Ameri- can Chemical Society, A. C. Cope Scholar Award (2010). Research field: organic synthesis, physical organic chemistry, nano-science.
Kazunori Kataoka, Ph.D., is a Professor of Biomaterials at Graduate School of Engineering, the University of Tokyo, Japan. He has been appointed joint position since 2004 from Graduate School of Medicine, the University of Tokyo as a Professor of Clinical Biotechnology at Center of Disease Biology and Integrative Medicine. He received B.Eng. (1974) and Ph.D. (1979) from the University of Tokyo.
Dr. Kataoka received the Society Award from the Japanese Society for Biomaterials (1993), the Society Award from the Society of Polymer Science, Japan (2000), Clemson Award from the Society for Biomaterials, USA (2005), Founders Award from the Controlled Release Society (2008), and The Prize for Science and Technology (Research Category), The Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology (MEXT). He has been a Fellow of the American Institute of Medical and Biological Engineering since 1999, and a vice president of the Society of Polymer Science, Japan since 2008.
His current major research interest includes the development of new polymeric carrier systems, especially block copolymer micelles, for drug and gene targeting.
Seth was born in Philadelphia, Pennsylvania in 1979. He grew up in Cheltenham, just outside the city, and in 1997 graduated from Valley Forge Military Academy (Wayne, PA). In 1998, he began his undergraduate studies at Temple University (Philadelphia, PA). There he conducted research in the laboratories of Professor Grant R. Krow, studying the synthesis and chemistry of highly strained azabicyclohexanes [such as N-(tert-butoxycarbonyl)-2-azabicylo[2.1.1]hexane]. In 2002 he moved to Cambridge, MA to begin his graduate studies at Harvard University. Under the guidance of Professor Andrew G. Myers, he developed enantioselective syntheses of the complex antiproliferative alkaloids avrainvillamide and stephacidin B. After graduating in 2006, he moved to the University of Illinois, Urbana-Champaign, to begin postdoctoral studies with Professor John F. Hartwig. At the U of I he was engaged in the study of new transition metal-mediated C–H bond functionalization reactions and the development of new methods for reaction discovery. In 2008 he joined the Yale Chemistry Department as an Assistant Professor of Chemistry.
1999.12–present: Professor; 1997.9–2000.11: Associate Professor; 1996.9–1997.8: Assistant Professor, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences 1995.9–1996.8: Postdoc, Dept. of Chemistry, New York University 1992-1995: Ph.D. in Organic Chemistry; 1989-1992: M.S. in Organic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences 1985-1989: B.S. in Nuclear Chemistry, Peking University
Total Synthesis, Synthetic Methodology, and Chemical Biology of biologically significant oligosaccharides, glycoconjugates, and other natural products, especially the glycosaminoglycans of mammal, antibiotics of microbe, glycosides of plants and marine species. And Chemistry of the Traditional Chinese Medicine.
1997: ‘Award for Invention’ (2nd class), Chinese Academy of Sciences 1998: ‘Young Chemist Award’, Chinese Chemical Society 1998-1999: ‘Outstanding Young Researcher’, Shanghai 1999: ‘Meiji Life Science Award’, Meiji Co., Shanghai 1999,2002: ‘Rising Star (Grant)’, The Science and Technology Committee of Shanghai 2000: ‘Outstanding Young (Grant)’, The National Natural Science Foundation of China 2000: ‘Servier Young Investigator Awards in Medicinal Chemistry’, Chinese Pharmacological Society 2000: ‘Outstanding Young’, Chinese Academy of Sciences 2003: ‘Hundreds Talents (Grant)’, Chinese Academy of Sciences 2004: ‘Outstanding Scholar’, Shanghai 2004: ‘Candidates of the National Talents’, China 2006: ‘Award for Natural Sciences’ (2nd class), Shanghai 2007: ‘Research Award for Life Chemistry’, WuXi Pharma Tech
Nobuyoshi Yasuda is Senior Investigator at Merck Research Laboratories, Process Research Department. He received his MS (1978) and his Ph.D (1987) from Tokyo Institute of Technology. He joined in Fujisawa Pharmaceutical Co. Ltd. in 1978 . He had studies at Colorado State University as a Post Doctorial Fellow (Prof. Robert M. Williams) from 1988 to 1989. He joined in Merck Process Research Labs. in 1990. His interests are Organic synthetic chemistry and music